|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.197
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.121
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.111
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.105
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.103
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.094
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.091
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.081
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.081
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.080
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.077
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.077
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.075
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.074
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.074
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.071
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.067
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.065
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.064
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.064
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.063
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.061
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.060
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.058
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.058
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.057
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.056
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.056
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.055
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.055
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.054
|
|
|
|
proteoglycan biosynthetic process
|
GO:0030166 |
20 |
0.054
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.053
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.052
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.052
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.052
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.051
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.051
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.050
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.050
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.050
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.049
|
|
|
|
regulation of ovulation
|
GO:0060278 |
3 |
0.049
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.049
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.049
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.049
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.047
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.047
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.046
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.046
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.046
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.045
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.045
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.044
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.044
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.044
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.044
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.044
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.043
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.043
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.043
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.043
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.042
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.042
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.042
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.042
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.041
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.041
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.041
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.041
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.041
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.041
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.040
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.039
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.039
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.039
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.038
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.037
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.037
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.037
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.037
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.037
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.036
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.036
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.036
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.036
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.035
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.035
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.035
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.035
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.035
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.035
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.035
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.035
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.034
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.034
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.034
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.033
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.033
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.033
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.033
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.033
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.032
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.032
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.032
|
|
|
|
glossopharyngeal nerve morphogenesis
|
GO:0021615 |
4 |
0.032
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.032
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.032
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.031
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.031
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.031
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.031
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.031
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.031
|
|
|
|
visceral motor neuron differentiation
|
GO:0021524 |
3 |
0.031
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.031
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.031
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.031
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.030
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.030
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.030
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.030
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.030
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.030
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.030
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.030
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.030
|
|
|
|
gonad morphogenesis
|
GO:0035262 |
1 |
0.029
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.029
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.029
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.029
|
|
|
|
rhombomere formation
|
GO:0021594 |
1 |
0.029
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.029
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.029
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.029
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.028
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.028
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.028
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.028
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.028
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.028
|
|
|
|
forebrain radial glial cell differentiation
|
GO:0021861 |
4 |
0.028
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.028
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.028
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.028
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.027
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.027
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.027
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.027
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.026
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.026
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.026
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.026
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.026
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.026
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.026
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.026
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.025
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.025
|
|
|
|
vagus nerve morphogenesis
|
GO:0021644 |
2 |
0.025
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.025
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.025
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.025
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.025
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.025
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.025
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.025
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.025
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.025
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.025
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.025
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.025
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.024
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.024
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.024
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.024
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.024
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.024
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.024
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.024
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.024
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.024
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.024
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.024
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.024
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.023
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.023
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.023
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.023
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.023
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.023
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.023
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.023
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.023
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.023
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.023
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.023
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.023
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.023
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.023
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.023
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.023
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.023
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.022
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.022
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.022
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.022
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.022
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.022
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.022
|
|
|
|
his purkinje system cell differentiation
|
GO:0060932 |
2 |
0.022
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.022
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.022
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.022
|
|
|
|
regulation of tongue muscle cell differentiation
|
GO:2001035 |
2 |
0.022
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.021
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.021
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.021
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.021
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.021
|
|
|
|
regulation of mesenchymal cell proliferation involved in ureter development
|
GO:0072199 |
3 |
0.021
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.021
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.021
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.021
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.021
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.021
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.021
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.021
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.021
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.021
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.021
|
|
|
|
regulation of cardiac chamber morphogenesis
|
GO:1901219 |
2 |
0.020
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.020
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.020
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.020
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.020
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.020
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.020
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.020
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.020
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.020
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.020
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.020
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.020
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
35 |
0.019
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.019
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.019
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.019
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.019
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.019
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.019
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.019
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.019
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.019
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.019
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.019
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.019
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.019
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.019
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.019
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.019
|
|
|
|
oocyte maturation
|
GO:0001556 |
18 |
0.019
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.019
|
|
|
|
neuron maturation
|
GO:0042551 |
29 |
0.018
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.018
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.018
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.018
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.018
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.018
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.018
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.018
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.018
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.018
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.018
|
|
|
|
negative regulation of ovulation
|
GO:0060280 |
1 |
0.018
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.018
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.018
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.018
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.018
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.018
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.018
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.018
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.018
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.018
|
|
|
|
heart formation
|
GO:0060914 |
16 |
0.018
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.018
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.018
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.018
|
|
|
|
positive regulation of t cell differentiation in thymus
|
GO:0033089 |
13 |
0.018
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.017
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.017
|
|
|
|
cell migration involved in endocardial cushion formation
|
GO:0003273 |
3 |
0.017
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.017
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.017
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.017
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.017
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.017
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.017
|
|
|
|
tricuspid valve development
|
GO:0003175 |
3 |
0.017
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.017
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.017
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.017
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.017
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.017
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.017
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.017
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.017
|
|
|
|
regulation of skeletal muscle fiber differentiation
|
GO:1902809 |
3 |
0.017
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.017
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.017
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.017
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.017
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.017
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.017
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.017
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.017
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.017
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.017
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.016
|
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.016
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.016
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.016
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.016
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.016
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.016
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.016
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.016
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.016
|
|
|
|
olfactory bulb development
|
GO:0021772 |
30 |
0.016
|
|
|
|
positive regulation of mesoderm development
|
GO:2000382 |
2 |
0.016
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.016
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.016
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.016
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.016
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.016
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.016
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.016
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.016
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.016
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.016
|
|
|
|
negative regulation of cardiac chamber morphogenesis
|
GO:1901220 |
2 |
0.016
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.016
|
|
|
|
positive regulation of mesenchymal cell proliferation involved in ureter development
|
GO:2000729 |
3 |
0.016
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.016
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.016
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.016
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.016
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.016
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.016
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.015
|
|
|
|
regulation of synapse structural plasticity
|
GO:0051823 |
4 |
0.015
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.015
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.015
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.015
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.015
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.015
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.015
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.015
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.015
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.015
|
|
|
|
mesodermal to mesenchymal transition involved in gastrulation
|
GO:0060809 |
1 |
0.015
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.015
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.015
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.015
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.015
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.015
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.015
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
26 |
0.015
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.015
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.015
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.015
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.015
|
|
|
|
tongue muscle cell differentiation
|
GO:0035981 |
2 |
0.015
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.015
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.015
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.015
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.015
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.015
|
|
|
|
parasympathetic nervous system development
|
GO:0048486 |
19 |
0.015
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.015
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.015
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.015
|
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.015
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.015
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
4 |
0.015
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.015
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.015
|
|
|
|
regulation of cardiac chamber formation
|
GO:1901210 |
1 |
0.014
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.014
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.014
|
|
|
|
growth involved in heart morphogenesis
|
GO:0003241 |
4 |
0.014
|
|
|
|
preganglionic parasympathetic nervous system development
|
GO:0021783 |
17 |
0.014
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.014
|
|
|
|
postganglionic parasympathetic nervous system development
|
GO:0021784 |
2 |
0.014
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.014
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.014
|
|
|
|
mammary placode formation
|
GO:0060596 |
4 |
0.014
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.014
|
|
|
|
triglyceride biosynthetic process
|
GO:0019432 |
17 |
0.014
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.014
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.014
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.014
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.014
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.014
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.014
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.014
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.014
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.014
|
|
|
|
negative regulation of calcium ion dependent exocytosis
|
GO:0045955 |
3 |
0.014
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.014
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.014
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.014
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.014
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.014
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.014
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.014
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.014
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.014
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.014
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.014
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.014
|
|
|
|
female sex determination
|
GO:0030237 |
1 |
0.014
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.014
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.014
|
|
|
|
neuroblast fate determination
|
GO:0007400 |
1 |
0.013
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.013
|
|
|
|
recognition of apoptotic cell
|
GO:0043654 |
3 |
0.013
|
|
|
|
sinoatrial node cell development
|
GO:0060931 |
3 |
0.013
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.013
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.013
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.013
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.013
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.013
|
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.013
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.013
|
|
|
|
aminoglycan biosynthetic process
|
GO:0006023 |
15 |
0.013
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.013
|
|
|
|
smad protein complex assembly
|
GO:0007183 |
1 |
0.013
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.013
|
|
|
|
regulation of actin filament bundle assembly
|
GO:0032231 |
18 |
0.013
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.013
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.013
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.013
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.013
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.013
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.013
|
|
|
|
positive regulation of organ growth
|
GO:0046622 |
29 |
0.013
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.013
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.013
|
|
|
|
negative regulation of canonical wnt signaling pathway involved in neural plate anterior posterior pattern formation
|
GO:0060829 |
1 |
0.013
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.013
|
|
|
|
cardiac muscle cell myoblast differentiation
|
GO:0060379 |
8 |
0.013
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.013
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.013
|
|
|
|
dendritic spine development
|
GO:0060996 |
30 |
0.013
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.013
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.013
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.013
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.013
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.013
|
|
|
|
pulmonary valve formation
|
GO:0003193 |
1 |
0.013
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.013
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.013
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.013
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
2 |
0.013
|
|
|
|
compartment pattern specification
|
GO:0007386 |
4 |
0.012
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.012
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.012
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.012
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.012
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.012
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.012
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.012
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.012
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.012
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.012
|
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.012
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.012
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.012
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.012
|
|
|
|
positive regulation of skeletal muscle fiber differentiation
|
GO:1902811 |
2 |
0.012
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.012
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.012
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.012
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.012
|
|
|
|
chondroitin sulfate proteoglycan biosynthetic process
|
GO:0050650 |
8 |
0.012
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.012
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.012
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.012
|
|
|
|
immunoglobulin production involved in immunoglobulin mediated immune response
|
GO:0002381 |
43 |
0.012
|
|
